Erlotinib Tablets IP

A form of targeted therapy used to treat cancer is erlotinib. A tyrosine kinase inhibitor known as erlotinib inhibits the kinase activity of the protein known as epidermal growth factor receptor (EGFR), which is essential for cell growth and survival. Pancreatic cancer and non-small cell lung cancer are both treated with erlotinib (NSCLC). Exon 19 deletions or exon 21 substitution mutations in the EGRF protein are the only types of NSCLC that can be treated with it. On the surface of both healthy and malignant cells, EGFR is present. We are a well-known supplier, wholesaler, dealer, exporter, and retailer of Erlotinib Tablets IP.

Product details